Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Prepaid Assets: 2019-2024

Historic Prepaid Assets for Silence Therapeutics (SLN) over the last 6 years, with Dec 2024 value amounting to $14.7 million.

  • Silence Therapeutics' Prepaid Assets was N/A to $9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year change of. This contributed to the annual value of $14.7 million for FY2024, which is 26.09% up from last year.
  • As of FY2024, Silence Therapeutics' Prepaid Assets stood at $14.7 million, which was up 26.09% from $11.6 million recorded in FY2023.
  • Over the past 5 years, Silence Therapeutics' Prepaid Assets peaked at $14.7 million during FY2024, and registered a low of $5.1 million during FY2020.
  • Over the past 3 years, Silence Therapeutics' median Prepaid Assets value was $11.6 million (recorded in 2023), while the average stood at $12.1 million.
  • In the last 5 years, Silence Therapeutics' Prepaid Assets skyrocketed by 819.39% in 2020 and then dropped by 14.60% in 2023.
  • Silence Therapeutics' Prepaid Assets (MRY) stood at $5.1 million in 2020, then grew by 17.18% to $5.9 million in 2021, then skyrocketed by 71.18% to $10.1 million in 2022, then increased by 14.60% to $11.6 million in 2023, then grew by 26.09% to $14.7 million in 2024.
  • Its Prepaid Assets stands at $14.7 million for FY2024, versus $11.6 million for FY2023 and $10.1 million for FY2022.